Answers are grounded in this paper and cite their sources.
Intensive aquaculture of American bullfrogs ( Aquarana catesbeiana ) is increasingly challenged by poor water quality, disease outbreaks, and the overuse of antibiotics, underscoring the need for effective and sustainable health management strategies. This study evaluated the effects of dietary supplementation with Bacillus velezensis YSJ-24 on growth performance, antioxidant capacity, intestinal health, gut microbiota, and disease resistance in American bullfrogs. During a 28-day feeding trial, bullfrogs were fed a basal control diet or diets supplemented with B. velezensis YSJ-24 at 1 × 10⁷, 1 × 10⁸ or 1 × 10⁹ CFU/g, designated BV1, BV2, and BV3, respectively. Among the supplemented groups, BV2 showed the most pronounced beneficial effects, with an 8.6% increase in weight gain rate (WGR), an 8.0% increase in specific growth rate (SGR), and a 20.0% decrease in feed conversion ratio (FCR) compared with the NC (negative control) group. Dietary supplementation with YSJ-24 significantly enhanced intestinal antioxidant capacity, as indicated by increased superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase activities (CAT), together with reduced malondialdehyde (MDA) levels ( P < 0.05). Intestinal morphology was also improved, as evidenced by increased villus height and goblet cell density. Gut microbiota analysis revealed no significant changes in alpha diversity, although moderate compositional shifts were observed, including higher relative abundances of Prevotella and Bacteroides in the BV2 group. Following challenge with Streptococcus agalactiae , the survival rate of bullfrogs in the BV2 group reached 70.0%, whereas 0% survival was observed in the NC group. Overall, these findings indicate that dietary B. velezensis YSJ-24, particularly at 1 × 10⁸ CFU/g, improves growth performance, intestinal health, antioxidant status, and resistance to bacterial infection in American bullfrogs. This strain may serve as a promising functional feed additive for health management in intensive bullfrog aquaculture.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: